PLRTF yields 5442.18% · MRK yields 2.81%● Live data
📍 PLRTF pulled ahead of the other in Year 1
Combined, PLRTF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLRTF + MRK for your $10,000?
Plymouth Rock Technologies Inc. focuses on developing security screening and threat detection technology solutions using radar imaging and signal processing technology. Its technologies include Wireless Threat Indication, a wall or portal mounted sensor system that will detect concealed threat items over an extended coverage area; Shoe Scanner, a compact microwave radar system for scanning shoes; Millimeter Remote Imaging from Airborne Drone; PRT-X1, an unmanned aerial system (UAS) drone; XV, a fixed-wing UAS platform with the added capability of vertical take-off and landing; X1, a purpose built coaxial multirotor UAS; and Cognitive Object Detection Apparatus, a compact modular radar for aircraft and weapon detection applications. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.
Full PLRTF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.